HGSI : Phase III Albuferon fails to offer major benifits Here's the article: <a href="http://drugdiscovery.pharmaceutical-business-review.com/comment/human_genome_sciences_albuferon_unlikely_to_threaten_hcv_standard_of_care_200309" rel="nofollow" target="_blank">http://drugdiscovery.pharmaceutical-business-review.com/comment/human_genome_sciences_albuferon_unlikely_to_threaten_hcv_standard_of_care_200309</a>